BrowserStack, the world's leading software testing platform, today announced an ESOP and share buyback program of $125 million for its employees and early investors. The program will benefit over 500 ...
Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
Learn how to get the best rate on a home equity loan Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor for Buy Side. Edited By Written by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback